{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T13:43:39Z","timestamp":1785764619415,"version":"3.56.0"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,3,19]]},"DOI":"10.7759\/cureus.80860","type":"journal-article","created":{"date-parts":[[2025,3,20]],"date-time":"2025-03-20T05:58:14Z","timestamp":1742450294000},"source":"Crossref","is-referenced-by-count":2,"title":["Advancement in the Management of Synchronous Colorectal Liver Metastasis: A Comprehensive Review of Surgical, Systemic, and Local Treatment Modalities"],"prefix":"10.7759","author":[{"given":"Syed Hassan Raza","family":"Bokhari","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammad","family":"Hammad Muzaffar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Basil","family":"Ahmad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soondas","family":"Waheed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shabab U","family":"Rehman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Komal","family":"Syed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.12688\/f1000research.10324.1","article-title":"Contemporary surgical management of synchronous colorectal liver metastases","volume":"6","author":"Collins D","year":"2017","unstructured":"Collins D, Chua H. Contemporary surgical management of synchronous colorectal liver metastases. F1000Res. 2017, 6:598. 10.12688\/f1000research.10324.1","journal-title":"F1000Res"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1002\/bjs.7032","article-title":"Surgical management and outcomes of colorectal cancer liver metastases","volume":"97","author":"Morris EJ","year":"2010","unstructured":"Morris EJ, Forman D, Thomas JD, et al.. Surgical management and outcomes of colorectal cancer liver metastases. Br J Surg. 2010, 97:1110-8. 10.1002\/bjs.7032","journal-title":"Br J Surg"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.4254\/wjh.v4.i8.237","article-title":"Treatment strategy for colorectal cancer with resectable synchronous liver metastases: is any evidence-based strategy possible?","volume":"4","author":"Vigan\u00f2 L","year":"2012","unstructured":"Vigan\u00f2 L. Treatment strategy for colorectal cancer with resectable synchronous liver metastases: is any evidence-based strategy possible?. World J Hepatol. 2012, 4:237-41. 10.4254\/wjh.v4.i8.237","journal-title":"World J Hepatol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdw235","article-title":"ESMO consensus guidelines for the management of patients with metastatic colorectal cancer","volume":"27","author":"Van Cutsem E","year":"2016","unstructured":"Van Cutsem E, Cervantes A, Adam R, et al.. ESMO consensus guidelines for the management of patients with metastatic colorectal cancer. Ann Oncol. 2016, 27:1386-422. 10.1093\/annonc\/mdw235","journal-title":"Ann Oncol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1002\/bjs.9449","article-title":"Systematic review of surgical management of synchronous colorectal liver metastases","volume":"101","author":"Lykoudis PM","year":"2014","unstructured":"Lykoudis PM, O'Reilly D, Nastos K, Fusai G. Systematic review of surgical management of synchronous colorectal liver metastases. Br J Surg. 2014, 101:605-12. 10.1002\/bjs.9449","journal-title":"Br J Surg"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1097\/01.sla.0000141198.92114.f6","article-title":"Rescue surgery for unresectable colorectal liver metastases downstaged by chemotherapy: a model to predict long-term survival","volume":"240","author":"Adam R","year":"2004","unstructured":"Adam R, Delvart V, Pascal G, et al.. Rescue surgery for unresectable colorectal liver metastases downstaged by chemotherapy: a model to predict long-term survival. Ann Surg. 2004, 240:644-57; discussion 657-8. 10.1097\/01.sla.0000141198.92114.f6","journal-title":"Ann Surg"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/j.ctrv.2015.06.006","article-title":"Managing synchronous liver metastases from colorectal cancer: a multidisciplinary international consensus","volume":"41","author":"Adam R","year":"2015","unstructured":"Adam R, de Gramont A, Figueras J, et al.. Managing synchronous liver metastases from colorectal cancer: a multidisciplinary international consensus. Cancer Treat Rev. 2015, 41:729-41. 10.1016\/j.ctrv.2015.06.006","journal-title":"Cancer Treat Rev"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.6004\/jnccn.2021.0012","article-title":"Colon Cancer, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology","volume":"19","author":"Benson AB","year":"2021","unstructured":"Benson AB, Venook AP, Al-Hawary MM, et al.. Colon Cancer, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw. 2021, 19:329-59. 10.6004\/jnccn.2021.0012","journal-title":"J Natl Compr Canc Netw"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.21037\/hbsn.2019.05.14","article-title":"Surgical approach to synchronous colorectal liver metastases: staged, combined, or reverse strategy","volume":"9","author":"Lillemoe HA","year":"2020","unstructured":"Lillemoe HA, Vauthey JN. Surgical approach to synchronous colorectal liver metastases: staged, combined, or reverse strategy. Hepatobiliary Surg Nutr. 2020, 9:25-34. 10.21037\/hbsn.2019.05.14","journal-title":"Hepatobiliary Surg Nutr"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1007\/s00464-022-09612-0","article-title":"Minimally invasive versus open hepatectomy for the resection of colorectal liver metastases: a systematic review and meta-analysis","volume":"36","author":"Ozair A","year":"2022","unstructured":"Ozair A, Collings A, Adams AM, et al.. Minimally invasive versus open hepatectomy for the resection of colorectal liver metastases: a systematic review and meta-analysis. Surg Endosc. 2022, 36:7915-37. 10.1007\/s00464-022-09612-0","journal-title":"Surg Endosc"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1001\/jamasurg.2018.0996","article-title":"Association of BRAF mutations with survival and recurrence in surgically treated patients with metastatic colorectal liver cancer","volume":"153","author":"Margonis GA","year":"2018","unstructured":"Margonis GA, Buettner S, Andreatos N, et al.. Association of BRAF mutations with survival and recurrence in surgically treated patients with metastatic colorectal liver cancer. JAMA Surg. 2018, 153:e180996. 10.1001\/jamasurg.2018.0996","journal-title":"JAMA Surg"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1001\/archsurg.141.10.1006","article-title":"Selection criteria for simultaneous resection in patients with synchronous liver metastasis","volume":"141","author":"Minagawa M","year":"2006","unstructured":"Minagawa M, Yamamoto J, Miwa S, et al.. Selection criteria for simultaneous resection in patients with synchronous liver metastasis. Arch Surg. 2006, 141:1006-12; discussion 1013. 10.1001\/archsurg.141.10.1006","journal-title":"Arch Surg"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1007\/s11605-008-0508-9","article-title":"Survival of patients with synchronous and metachronous colorectal liver metastases--is there a difference?","volume":"12","author":"Bockhorn M","year":"2008","unstructured":"Bockhorn M, Frilling A, Fr\u00fchauf NR, et al.. Survival of patients with synchronous and metachronous colorectal liver metastases--is there a difference?. J Gastrointest Surg. 2008, 12:1399-405. 10.1007\/s11605-008-0508-9","journal-title":"J Gastrointest Surg"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.3390\/molecules28093746","article-title":"Combination chemotherapy with selected polyphenols in preclinical and clinical studies-an update overview","volume":"28","author":"Jakobu\u0161i\u0107 Brala C","year":"2023","unstructured":"Jakobu\u0161i\u0107 Brala C, Karkovi\u0107 Markovi\u0107 A, Kugi\u0107 A, Tori\u0107 J, Barbari\u0107 M. Combination chemotherapy with selected polyphenols in preclinical and clinical studies-an update overview. Molecules. 2023, 28:3746. 10.3390\/molecules28093746","journal-title":"Molecules"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1097\/SLA.0000000000000614","article-title":"Phase II trial of hepatic artery infusional and systemic chemotherapy for patients with unresectable hepatic metastases from colorectal cancer: conversion to resection and long-term outcomes","volume":"261","author":"D\u02bcAngelica MI","year":"2015","unstructured":"D\u02bcAngelica MI, Correa-Gallego C, Paty PB, et al.. Phase II trial of hepatic artery infusional and systemic chemotherapy for patients with unresectable hepatic metastases from colorectal cancer: conversion to resection and long-term outcomes. Ann Surg. 2015, 261:353-60. 10.1097\/SLA.0000000000000614","journal-title":"Ann Surg"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjc.6603033","article-title":"Surgical resection of hepatic metastases from colorectal cancer: a systematic review of published studies","volume":"94","author":"Simmonds PC","year":"2006","unstructured":"Simmonds PC, Primrose JN, Colquitt JL, Garden OJ, Poston GJ, Rees M. Surgical resection of hepatic metastases from colorectal cancer: a systematic review of published studies. Br J Cancer. 2006, 94:982-99. 10.1038\/sj.bjc.6603033","journal-title":"Br J Cancer"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.14366\/usg.22208","article-title":"Ablation therapy for patients with colorectal liver metastases with and without extrahepatic metastases: evaluation of long-term outcomes and prognostic factors","volume":"42","author":"Klubien J","year":"2023","unstructured":"Klubien J, Rosenberg J, Skjoldbye BO, Lorentzen T, Nols\u00f8e CP, Pommergaard HL. Ablation therapy for patients with colorectal liver metastases with and without extrahepatic metastases: evaluation of long-term outcomes and prognostic factors. Ultrasonography. 2023, 42:410-20. 10.14366\/usg.22208","journal-title":"Ultrasonography"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1016\/j.hoc.2022.02.007","article-title":"Local therapies in advanced colorectal cancer","volume":"36","author":"Hitchcock KE","year":"2022","unstructured":"Hitchcock KE, Romesser PB, Miller ED. Local therapies in advanced colorectal cancer. Hematol Oncol Clin North Am. 2022, 36:553-67. 10.1016\/j.hoc.2022.02.007","journal-title":"Hematol Oncol Clin North Am"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1097\/AS9.0000000000000350","article-title":"Minimal invasive versus open surgery for colorectal liver metastases: a multicenter German Studoq|liver registry-based cohort analysis in Germany","volume":"4","author":"Moosburner S","year":"2023","unstructured":"Moosburner S, Kettler C, Hillebrandt KH, et al.. Minimal invasive versus open surgery for colorectal liver metastases: a multicenter German Studoq|liver registry-based cohort analysis in Germany. Ann Surg Open. 2023, 4:e350. 10.1097\/AS9.0000000000000350","journal-title":"Ann Surg Open"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1016\/j.hpb.2019.03.358","article-title":"Laparoscopic versus open liver resection in the posterosuperior segments: a sub-group analysis from the OSLO-COMET randomized controlled trial","volume":"21","author":"Aghayan DL","year":"2019","unstructured":"Aghayan DL, Fretland \u00c5A, Kazaryan AM, et al.. Laparoscopic versus open liver resection in the posterosuperior segments: a sub-group analysis from the OSLO-COMET randomized controlled trial. HPB (Oxford). 2019, 21:1485-90. 10.1016\/j.hpb.2019.03.358","journal-title":"HPB (Oxford)"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1097\/SLA.0000000000002319","article-title":"RAS mutation clinical risk score to predict survival after resection of colorectal liver metastases","volume":"269","author":"Brudvik KW","year":"2019","unstructured":"Brudvik KW, Jones RP, Giuliante F, et al.. RAS mutation clinical risk score to predict survival after resection of colorectal liver metastases. Ann Surg. 2019, 269:120-6. 10.1097\/SLA.0000000000002319","journal-title":"Ann Surg"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.3233\/efi-180221","article-title":"The mixed methods appraisal tool (MMAT) version 2018 for information professionals and researchers","volume":"34","author":"Hong QN","year":"2018","unstructured":"Hong QN, F\u00e0bregues S, Bartlett G, et al.. The mixed methods appraisal tool (MMAT) version 2018 for information professionals and researchers. Educ Inform. 2018, 34:285-91. 10.3233\/efi-180221","journal-title":"Educ Inform"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.14701\/ahbps.22-043","article-title":"Simultaneous resection of synchronous colorectal liver metastasis: feasibility and development of a prediction model","volume":"27","author":"Kazi M","year":"2023","unstructured":"Kazi M, Patkar S, Patel P, Kunte A, Desouza A, Saklani A, Goel M. Simultaneous resection of synchronous colorectal liver metastasis: feasibility and development of a prediction model. Ann Hepatobiliary Pancreat Surg. 2023, 27:40-8. 10.14701\/ahbps.22-043","journal-title":"Ann Hepatobiliary Pancreat Surg"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2023.46094","article-title":"Liver metastases and immune checkpoint inhibitor efficacy in patients with refractory metastatic colorectal cancer: a secondary analysis of a randomized clinical trial","volume":"6","author":"Chen EX","year":"2023","unstructured":"Chen EX, Loree JM, Titmuss E, et al.. Liver metastases and immune checkpoint inhibitor efficacy in patients with refractory metastatic colorectal cancer: a secondary analysis of a randomized clinical trial. JAMA Netw Open. 2023, 6:e2346094. 10.1001\/jamanetworkopen.2023.46094","journal-title":"JAMA Netw Open"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.4174\/astr.2024.107.5.264","article-title":"Primary tumor sidedness is not prognostic factor in resectable colorectal cancer liver metastasis: a retrospective observational cohort study","volume":"107","author":"Jo SJ","year":"2024","unstructured":"Jo SJ, Kim J, Shin JK, Rhu J, Huh JW, Choi GS, Joh JW. Primary tumor sidedness is not prognostic factor in resectable colorectal cancer liver metastasis: a retrospective observational cohort study. Ann Surg Treat Res. 2024, 107:264-73. 10.4174\/astr.2024.107.5.264","journal-title":"Ann Surg Treat Res"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.3390\/cancers16050857","article-title":"Perioperative chemotherapy including bevacizumab in potentially curable metastatic colorectal cancer: long-term follow-up of the ASSO-LM1 trial","volume":"16","author":"Dong Y","year":"2024","unstructured":"Dong Y, Santol J, Gruenberger B, et al.. Perioperative chemotherapy including bevacizumab in potentially curable metastatic colorectal cancer: long-term follow-up of the ASSO-LM1 trial. Cancers (Basel). 2024, 16:857. 10.3390\/cancers16050857","journal-title":"Cancers (Basel)"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1016\/j.jamcollsurg.2012.12.029","article-title":"Surgical management of patients with synchronous colorectal liver metastasis: a multicenter international analysis","volume":"216","author":"Mayo SC","year":"2013","unstructured":"Mayo SC, Pulitano C, Marques H, et al.. Surgical management of patients with synchronous colorectal liver metastasis: a multicenter international analysis. J Am Coll Surg. 2013, 216:707-16; discussion 716-8. 10.1016\/j.jamcollsurg.2012.12.029","journal-title":"J Am Coll Surg"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1007\/s00464-022-09493-3","article-title":"Laparoscopic parenchyma-sparing liver resection for large (\u2265\u200950\u00a0mm) colorectal metastases","volume":"37","author":"Aghayan DL","year":"2023","unstructured":"Aghayan DL, d'Albenzio G, Fretland \u00c5A, et al.. Laparoscopic parenchyma-sparing liver resection for large (\u2265\u200950\u00a0mm) colorectal metastases. Surg Endosc. 2023, 37:225-33. 10.1007\/s00464-022-09493-3","journal-title":"Surg Endosc"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.21037\/jovs-23-23","article-title":"Robotic left hepatectomy for colorectal liver metastases with modified rubber-band technique: surgical technique & steps","volume":"9","author":"Nadkarni S","year":"2023","unstructured":"Nadkarni S, Patkar S, Goel M. Robotic left hepatectomy for colorectal liver metastases with modified rubber-band technique: surgical technique & steps. J Vis Surg. 2023, 9:49. 10.21037\/jovs-23-23","journal-title":"J Vis Surg"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjsurg.2022.11.015","article-title":"Simultaneous versus staged resection for synchronous colorectal liver metastases: the win ratio approach","volume":"225","author":"Endo Y","year":"2023","unstructured":"Endo Y, Alaimo L, Araujo Lima H, et al.. Simultaneous versus staged resection for synchronous colorectal liver metastases: the win ratio approach. Am J Surg. 2023, 225:461-5. 10.1016\/j.amjsurg.2022.11.015","journal-title":"Am J Surg"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1016\/j.gassur.2024.01.034","article-title":"Simultaneous resection for colorectal cancer with synchronous liver metastases: current state-of-the-art","volume":"28","author":"Machairas N","year":"2024","unstructured":"Machairas N, Di Martino M, Primavesi F, et al.. Simultaneous resection for colorectal cancer with synchronous liver metastases: current state-of-the-art. J Gastrointest Surg. 2024, 28:577-86. 10.1016\/j.gassur.2024.01.034","journal-title":"J Gastrointest Surg"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.1097\/SLA.0000000000006267","article-title":"Robotic versus laparoscopic liver resection in various settings: an international multicenter propensity score matched study of 10.075 patients","volume":"280","author":"Sijberden JP","year":"2024","unstructured":"Sijberden JP, Hoogteijling TJ, Aghayan D, et al.. Robotic versus laparoscopic liver resection in various settings: an international multicenter propensity score matched study of 10.075 patients. Ann Surg. 2024, 280:108-17. 10.1097\/SLA.0000000000006267","journal-title":"Ann Surg"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(15)00122-9","article-title":"FOLFOXIRI plus bevacizumab versus FOLFIRI plus bevacizumab as first-line treatment of patients with metastatic colorectal cancer: updated overall survival and molecular subgroup analyses of the open-label, phase 3 TRIBE study","volume":"16","author":"Cremolini C","year":"2015","unstructured":"Cremolini C. FOLFOXIRI plus bevacizumab versus FOLFIRI plus bevacizumab as first-line treatment of patients with metastatic colorectal cancer: updated overall survival and molecular subgroup analyses of the open-label, phase 3 TRIBE study. Lancet Oncol. 2015, 16:1306-15. 10.1016\/S1470-2045(15)00122-9","journal-title":"Lancet Oncol"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/djx015","article-title":"Local treatment of unresectable colorectal liver metastases: results of a randomized phase II trial","volume":"109","author":"Ruers T","year":"2017","unstructured":"Ruers T, Van Coevorden F, Punt CJ, et al.. Local treatment of unresectable colorectal liver metastases: results of a randomized phase II trial. J Natl Cancer Inst. 2017, 109:djx015. 10.1093\/jnci\/djx015","journal-title":"J Natl Cancer Inst"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejso.2013.07.087","article-title":"Radiological assessment of response to neoadjuvant transcatheter hepatic therapy with irinotecan-eluting beads (DEBIRI(\u00ae)) for colorectal liver metastases does not predict tumour destruction or long-term outcome","volume":"39","author":"Jones RP","year":"2013","unstructured":"Jones RP, St\u00e4ttner S, Dunne DF, et al.. Radiological assessment of response to neoadjuvant transcatheter hepatic therapy with irinotecan-eluting beads (DEBIRI(\u00ae)) for colorectal liver metastases does not predict tumour destruction or long-term outcome. Eur J Surg Oncol. 2013, 39:1122-8. 10.1016\/j.ejso.2013.07.087","journal-title":"Eur J Surg Oncol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/338822-advancement-in-the-management-of-synchronous-colorectal-liver-metastasis-a-comprehensive-review-of-surgical-systemic-and-local-treatment-modalities","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,20]],"date-time":"2025-03-20T05:58:18Z","timestamp":1742450298000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/338822-advancement-in-the-management-of-synchronous-colorectal-liver-metastasis-a-comprehensive-review-of-surgical-systemic-and-local-treatment-modalities"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,19]]},"references-count":35,"URL":"https:\/\/doi.org\/10.7759\/cureus.80860","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,3,19]]}}}